Louis Moore Bacon's BIO Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 55,000 shares of Bio-Rad Laboratories, Inc. (BIO) worth $15.42 M, representing 0.21% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in BIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 45,000 shares. Largest reduction occurred in Q1 2025, reducing 35,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Bio-Rad Laboratories (BIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Rad Laboratories (BIO) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +1,100 | New Buy | 1,100 | $479.02 |
| Q2 2023 | +23,900 | Add 2172.73% | 25,000 | $379.12 |
| Q3 2023 | -12,500 | Reduce 50.00% | 12,500 | $358.45 |
| Q4 2023 | -12,500 | Sold Out | 12,500 | $0.00 |
| Q3 2024 | +45,000 | New Buy | 45,000 | $334.58 |
| Q1 2025 | -35,000 | Reduce 77.78% | 10,000 | $243.56 |
| Q2 2025 | -10,000 | Sold Out | 10,000 | $0.00 |
| Q3 2025 | +55,000 | New Buy | 55,000 | $280.39 |
Louis Moore Bacon's Bio-Rad Laboratories Investment FAQs
Louis Moore Bacon first purchased Bio-Rad Laboratories, Inc. (BIO) in Q1 2023, acquiring 1,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Bio-Rad Laboratories, Inc. (BIO) for 11 quarters since Q1 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Bio-Rad Laboratories, Inc. (BIO) was in Q3 2025, adding 55,000 shares worth $15.42 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 55,000 shares of Bio-Rad Laboratories, Inc. (BIO), valued at approximately $15.42 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bio-Rad Laboratories, Inc. (BIO) represents approximately 0.21% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Bio-Rad Laboratories, Inc. (BIO) was 55,000 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.